Total Words:	4536
Words	Count 
young	1
paper	1
immunohistochemistry	1
offer	1
a.u	1
improve	1
intake	8
include	1
multimodal	3
been	12
improved	5
appropriateness	1
meta-analysis	2
over	1
any	4
Guided	1
application	1
dual	2
selective	1
amount	2
time-varying	1
rapid	1
compounds	1
fatal	1
are	24
sites	3
monitoring	1
25.8%	1
our	2
prospective	2
aid	2
56%	1
prolonged	1
them	3
female	2
iron	1
vulnerability	1
inverse	1
addition	1
recently	3
induced	3
comprehensive	1
aggressive	1
long	3
After	1
evaluation	2
enhancement	2
proteins	2
traumatic	3
resulted	1
come	1
serum	2
moist	1
estimated	1
phenotype	2
tumors	1
new	3
defines	1
CONCLUSIONS	2
total	2
concurrently	1
Despite	1
characteristics	2
treatment	15
suggest	3
93.45%	1
severe	2
i.e	2
concept	1
Tumour	1
death	1
filter	1
completion	2
hormonal	2
low	3
systemnumber	1
cornerstone	1
editing	1
Female	1
outperforms	1
proliferation	1
CBC	7
assess	2
resolution	2
near	2
10.0%	1
transform	3
earlier	1
46.0	1
developed	5
some	1
first	3
Improved	1
without	5
just	1
Conclusions	1
already	3
CRISPR-Cas9-based	1
malign	1
too	1
BAK	1
barcode	4
lymph	3
analysis	7
performance	1
cancer	96
9.5	1
expenditures	1
40000	1
sister	2
MATERIALS	1
relationship	2
HER1	1
clustering	1
semi-structured	1
how	2
LEVEL	1
into	2
SUVmax	5
there	3
recorded	2
recombination	1
kg/m2	1
Traumatic	2
feasible;	1
probe	6
6.1%	1
Information	1
dye	1
Further	2
analyzed	4
Among	1
continuing	1
Cox	1
combinations	1
play	1
4	1
receptor	9
routine	1
They	1
conjugated	1
molecular	4
emerging	2
surgical	3
disease	15
duration	3
contribution	1
other	5
relative	1
further	2
curbing	1
prolactinomas	2
indicative	1
clinic	2
Using	1
cell-related	1
allowed	1
BCL-2	1
systematically	1
between	15
checkpoint	1
report	2
fear	1
kidney	2
	57
yielded	1
tomography	2
lead	2
troponins	1
aforementioned	1
users	2
case	2
revealed	2
commonly	1
hormone	1
DEM	2
included	2
under	1
sisters'	1
interpretation	1
its	4
CXCR4	3
have	12
highest	1
several	2
Maximum	1
affected	1
obtained	2
marked	1
pharmacological	2
Our	2
dermatitis	1
largely	1
met	1
breast/axillary	1
post-diagnosis	5
tool	3
Here	2
allotting	1
promising	1
reserved	2
assume	1
p	7
conventional	1
attempted	1
address	1
history	11
15.3%	1
detectionof	1
magnetic	1
multiple	2
inclusion	1
distinguished	2
e.g.	1
vivo	5
Selective	1
biocompatibility	1
secondary	1
better	2
NPV	1
intra-operative	1
barriers	1
utility	1
IMAGING	1
imaging	28
showed	3
harmfulor	1
receiving	3
Conventional	1
Anti-HER2	1
lapatinib	1
tumor-specific	1
images	4
acute	1
overcome	2
VEGFB	1
directionality	1
adoption	1
using	14
Ag2S-NP	1
they	1
tumour	3
likely	1
one-year	1
classify	1
separately	1
discovery	2
due	6
powerful	1
ion	1
capecitabine	1
after	9
8	1
0.93	1
facilitate	1
ILC	1
BRD4	4
family	12
hinder	1
Ras	1
coupled	1
mutational	1
energy	1
dietary	3
bleeding	1
Cancer	4
AZD2281	1
benefits	1
MRI	10
technique	2
mass	2
OS	5
observed	4
So	1
triple-negative	1
She	1
protocol	1
term	1
19	1
There	1
aspirin	7
therefore	1
general	1
region	1
P	1
locally	1
changed	2
only	4
still	1
established	1
subjective	1
complex	2
self-examination	1
Similarly	1
signal	3
what	1
adenomas	2
negligible	1
developments	1
rule	1
few	1
diet	2
fluorescent	4
typical	1
can	4
signature	2
discovered	1
ratios	3
visual	1
platinum	2
personalistic	1
search	1
none	1
digital	1
intravenous	1
incorporate	1
.013	1
initial	1
regulating	1
variable	1
Therefore	4
<	1
micelles	1
radiology	1
drug	2
review	4
NAC	3
older	1
osteopontin	2
7.0%	1
later	3
targeted	4
preventive	3
life	2
significantly	9
she	1
Ulceration	1
Due	1
neuromas	3
expression	4
personal	4
derivatives	3
anti-HER2	3
identify	4
nude	1
promote	1
IORT	3
cytotoxicity	1
understanding	2
g/day	1
differentially	1
Efficacy	1
removed	1
among	5
two	3
high-dose	1
recombination-mediated	2
fast	2
pattern	1
performed	3
demonstrated	4
novel	4
Fatigue.In	1
Better	1
massive	1
factors	9
accurate	2
approach	3
so	1
replaced	1
underwent	1
extracted	1
For	1
I2	2
surgery	10
HRs	2
interview	1
gene	2
Patient	1
analyzing	1
thematic	1
through	3
could	3
All	1
result	3
herein	2
used	9
spite	1
harmless	1
microRNA	1
epidermal	2
less	1
finding	1
determined	2
rapidly	1
human	7
23	1
aim	2
CIs	1
different	4
PET/CT	1
given	1
population	3
including	2
early-onset	1
accuracy	2
decreases	1
generally	1
Performing	1
2.5Â h	1
but	3
bed	1
tracer	1
per	1
during	4
BRCAness	3
pill	1
shared	1
carcinogenesis	1
theory	1
transferable	1
while	3
intractable	1
standardized	2
induction	1
radiation	2
DiR	1
techniqueused	1
abbreviated	5
recovery	1
nanoparticles	2
give	1
may	9
find	2
types	3
main	3
cardiotoxicity	6
caner	1
breast	91
dose	1
alternative	1
fluorophore	1
investigations	1
NFPA	2
does	2
occurred	1
trastuzumab-induced	1
contrast-enhanced	2
experiences	2
44%	1
trials	2
modified	1
causation	1
Noteworthy	1
Osteopontin-750	1
percent	1
agent	4
second-	2
limitations	1
retrospective	4
PA	11
10.3%	1
occurrence	1
outcomes	2
each	3
1200	1
inception	1
diagnoses	1
following	3
estrogen	3
range	2
More	2
Diagnosis	2
healthcare	3
non-ideal	1
needed	2
for	42
Negative	1
cost	1
obtain	1
control	3
time	4
experiment	1
HER2	5
biomarkers	2
oxide	1
targeting	1
literature	2
evidenced	1
indicate	1
5	1
was	32
systemic	3
no	4
detectable	2
ER	1
VEGFC	1
95%	5
chest	4
younger	1
mean	2
lack	1
anthracycline	1
combined	2
value	3
clinicians	1
model	4
Interestingly	1
Technical	1
Both	1
contraception	2
interval	2
X-ray	2
number	1
therapy	5
in	117
consultation	1
described	1
lycopene	1
simplify	1
diagnosis	24
good	2
inhibitors	4
3.0	1
update	1
IO-NP	1
detection	6
P=0.4	1
Furthermore	2
derived	1
negative	5
12-15%	1
ethinyl	1
30.1%	1
Given	1
effect	1
considering	1
choice	1
newly	1
acquisition	1
Notably	1
especially	2
perceive	1
BET	5
Conservative	1
overall	3
designed	1
cTn	7
osteopontin-750	1
tissue	1
direct	2
unresectable	1
shorten	1
The	22
than	11
minimal	1
routinely	1
unusual	1
received	4
BCL-W	1
having	1
cardiovascular	1
infrared	3
Moreover	2
Extra-Terminal	1
EMBASE	1
lesions	4
84%	1
resulting	1
Result	1
visually	3
shown	1
modality	2
study	12
along	1
target	1
called	1
Her	1
EF	2
relatively	1
the	132
6.8%	1
intrinsic	1
cohort	6
III	1
production	7
PI3K/Akt/mTOR	1
applied	4
invasive	4
CDDP	1
longer	1
if	1
perception	1
wild-type	2
all	6
necessity	1
computed	1
Objective	1
efficient	1
asymptomatic	1
transtuzumab-induced	1
patient's	1
inhibition	3
collected	1
respondents	1
patient	9
treated	3
clear	1
myocardial	1
untargeted	1
strategies	3
distinguish	1
Overall	2
about	1
deterioration	1
BC	4
possible	1
distant	2
would	2
0.033;	1
RAD51	1
salts	2
features	2
BRCA1/RAD51	1
RNA	2
MR	4
examination	2
overview	1
special	1
at-risk	1
year	3
1	3
living	1
0.50-0.99;	1
Bromodomain	1
properly	1
supplement	1
scan	1
surveillance	2
Breast	10
contribute	1
perform	1
investigated	3
25%-30%	1
available	4
subtypes	3
more	9
introduced	2
An	1
method	1
survivors	2
generate	1
12	2
must	1
besides	1
multispectral	1
palliative	1
BAX	1
seems	2
formation	1
positive	3
particular	2
avoid	1
DCE-MRI	2
symptom	1
CT	2
A	10
prescriptions	1
plan	1
Comparison	1
association	9
predict	1
which	7
wane	1
require	1
1996	1
behaviors	1
biology	2
whether	2
Danish	2
82.5	1
CXCR4-targeted	4
spectrometry	1
peptide	1
placed	1
summarize	1
four-month	1
heterogeneous	2
12.1%	1
her	3
compare	1
ErbB	1
much	1
Forty-two	1
apparent	1
nodes	2
subtype-specific	3
worldwide	2
Ten	1
defined	1
radiologist	1
If	1
both	3
an	17
current	3
ondata	1
vs	5
2018	2
members	4
major	2
cancercells	1
Healthcare	1
mammographic	1
advances	1
phantom	1
consider	1
proportional	1
confirmation	1
provide	2
develop	2
accumulation	4
silver	2
In	11
mannose	1
those	1
finances	1
impaired	1
cells	6
synthetic	1
representative	1
repair	4
view	1
trend	1
binding	2
=	9
medical	1
multiresolution	1
progesterone	1
reflect	1
genetic	2
a	77
exhibiting	1
adjustment	1
Altogether	1
CXCR4-directed	2
contours	1
regression	1
benign	3
Transcripts	1
Meta-regression	1
were	23
01.01.2010	1
Herein	1
counseling	1
lower	1
response	2
predisposing	1
classifier	1
pathways	1
9.7	1
Because	1
beliefs	1
pain	2
greater	1
intervals	2
b-carotene	3
neuropathic	2
filled	1
order	1
type	7
requiring	1
HER2+	3
third-degree	2
accomplished	1
13	2
vitro	3
Aims	1
Nine	1
presented	2
triple	3
Ras/MAPK	1
Methods	1
urgently	1
a.u.	2
cohort;	1
2005-2017	1
focusing	1
nationwide	2
fee-for-service	1
completing	1
times	1
hazard	4
mice	1
sulfide	1
assessment	1
aims	2
recognized	1
31	1
segmentation	1
0.91	1
values	1
0.004	2
symptoms	1
excluded	1
thus	1
pursue	1
status	3
originally	2
According	1
found	3
syndromes	1
associated	6
0.88-0.99;	1
0.015	1
flow	1
extent	2
ability	2
underutilized	1
wavelet	2
methods	2
contralateral	2
unresected	2
We	10
responsible	1
rising	1
54%	1
primary	8
interference	1
directly	1
profiles	2
BCL-X	1
now	2
has	12
four	4
DWI	1
specificities	1
University	1
Stage	1
axillary	1
set	1
body	1
via	1
RESULTS	4
b-cryptoxanthin	1
regulators	1
comparing	1
LABC	2
As	1
families	2
8/18	1
requires	1
0-3012.5	1
transtuzumab	1
behavior	2
six	1
examinations	1
17	1
often	1
Filipino	1
lesion	3
means	1
this	13
formulation	1
molecule	1
cell	4
results	8
relapsed	3
10.9	2
patients	48
helps	1
agreement	1
METHODS	3
J	1
thesuspicious	1
network	1
cardiotoxicity;	1
fluorescence	1
24	2
high-risk	1
correlation	2
demographics	1
mastectomy	3
timing	1
Ulm	1
calculate	1
CI	1
Thus	1
inheritance	1
limited	1
disproportionate	1
MCL-1	1
When	1
Patients	2
doses	2
outcome	2
potential	1
resonance	1
reproducibility	1
subtype	1
study;	1
involves	2
agents	4
antibodies	1
sampled	1
computational	1
appears	1
collect	1
high	7
currently	2
PR	1
uptake	1
therapeutic	4
HER3	1
metastasis	2
one	5
increased	5
women	13
shrinkage	2
regulation	2
Their	1
biomarker	3
from	9
date	1
monoclonal	1
well	1
detected	1
Radiotherapy	1
summary	2
identification	3
consistent	1
lowest	1
will	1
Twenty-six	1
widespread	1
trial	1
radical	1
Multi-scale	1
stratification	2
very	6
adjusted	1
advance	1
vitamin	4
sibling	1
HR	1
mutations	2
prognosis	4
metastases	2
views	1
precision	1
costs	2
models	2
ER+	1
index	3
approaches	3
excision	1
BACKGROUND	4
genes	3
presentation	4
lung	5
organs	2
immunoprecipitation	1
screening	9
components	5
imagesneed	1
we	12
This	7
measured	2
who	1
28	1
however	3
policy	1
Triple	1
contrast	10
Metastases	1
5.8%	1
years	8
out	1
Anthracyclines	1
tissues	1
motivation	1
homologous	3
invariance	1
suggesting	1
administration	1
ERK	1
article	2
preliminary	1
findings	2
when	5
immunotherapy-based	1
sought	2
recurrent	5
eg	1
as	25
proposed	2
"all-in-one"	1
signaling	1
medicine	1
survival	8
apoptosis	1
leading	1
progression-free	2
prediagnosis	1
independent	2
issues	2
versus	1
Locoregional	1
Fluorescence	1
is	44
chart	1
radiologists	1
impact	1
States	1
classification	1
phenomenological	1
causes	1
gives	1
shift	1
Median	4
details	1
Although	2
mechanisms	1
Mammography	1
DDSM	1
Colorectal	1
safety	1
acromegaly	1
p53	1
effects	4
prior	1
according	1
tumour-related	1
discomfort	1
lethality	1
35	1
generating	1
Hospital	1
indicates	1
accumulated	2
20-mcg	1
diagnosed	8
nanoparticle	1
framework	1
locoregional	2
five	3
consultations	1
breast-conserving	1
mainly	3
BMI	1
experienced	1
osteopontin-based	2
themselves	1
12.4%	1
substantial	1
member	1
burden	1
JQ1	1
tumor-to-background	1
4.8	1
post-injection	1
difficult	1
particularly	1
unknown	2
Lung	1
3.5	1
conserving	1
node	1
test	1
non-functioning	1
60	2
37.5%	1
Six	1
coefficients	1
advanced	3
32.1	1
Unfortunately	1
cytometry	1
potent	1
liver	2
prognostic	10
done	1
Results	1
lag	1
since	1
581	1
seem	1
numerous	1
preclinical	1
fraction	2
VEGF	2
However	5
implemented	2
utilized	1
validated	1
assessing	2
experience	1
locus	1
protected	1
pathway	4
mammography	5
nontarget	2
with	87
2	3
data	2
January	1
gene-expression-based	2
specific	4
2004	1
breasts	1
dysfunction	1
trastuzumab	1
explained	1
31.12.2014	1
populations	1
increase	2
investigation	1
able	1
numbers	1
proportion	1
options	3
median	2
role	3
stage	2
Shearlet	4
cycle	1
near-infrared	2
purposively	1
radiotherapy	11
because	2
understand	1
their	10
sensitive	3
rare	3
preferentially	1
useful	2
get	1
intrauterine	1
confidence	4
low-dose	6
important	4
anthracyclines	3
wall	4
directional	1
length	1
undetectable	1
misdiagnosis	1
clearly	1
dynamic	1
DNA	6
value-based	2
it	6
0.75-1.09	1
neoadjuvant	3
previous	4
exposure	2
discussed	2
levonorgestrel	1
evidence	3
corresponding	1
PGF	1
applications	1
a-carotene	1
To	1
Diagnostic	1
1062	1
Cardiac	1
these	6
research	1
explore	1
release	1
conducted	3
Thirteen	1
techniques	1
alone	1
process	2
carcinoma	2
most	9
easily	1
detectability	1
be	16
chromatin	1
axilla	1
inhibitors-based	1
combination	1
16.4	1
larger	1
EVIDENCE	1
errors	2
scrutiny	1
ml	2
MSOT	6
levels	2
0.02;	1
Aided	2
validating	1
functional	1
ratio	1
follow-up	3
signatures	5
Based	2
small	6
concerns	2
necessary	3
36	1
treatments	1
suitable	2
MEK	1
pooled	1
at	9
precise	1
diffusion-weighted	1
development	3
2012	1
T/B	1
sampling	1
relatives	2
ex	1
drains	1
multi-omics	1
image	4
0.001	1
reduction	3
or	14
HER4	1
inhibitor-	1
0.049	1
effective	4
wound	1
properties	1
of	180
diagnostic	6
months	4
management	4
desquamation	1
investigate	1
therapies	2
importantly	1
variation	3
retinol	1
led	1
Forty-three	1
studies	12
existing	1
MAGN	1
maintaining	1
People	1
makers	1
clinical	9
utilizing	1
Efforts	1
metastatic	3
constructing	1
grade	2
atechnique	1
injection	1
remains	2
regional	1
detecting	1
tend	1
P=0.2	1
frequently	1
did	4
38.7%	1
cardiac	4
cancer-specific	1
toxicity	1
estradiol	1
present	5
regulate	1
glycosylation	3
lines	1
historically	1
Observational	1
locally-advanced	2
algorithm	2
inquiry	1
treatment;	1
NIRF	2
cancers	5
exam	1
72	1
entity	1
feasible	2
predictive	1
indicator	1
far	2
presence	2
high-resolution	1
early	4
recent	4
cardiotoxicities	1
quality	1
criteria	1
confirmed	3
risk	21
related	1
increment	1
46.6%	1
60%	1
whole	1
PubMed	1
might	1
higher	7
3	1
identified	4
filters	1
18F-FDG	3
drugs	1
prolactinoma	4
stratified	1
OF	1
involved	4
appealing	1
25.6	1
that	24
protocols	4
many	1
lobular	1
Cooperative	1
sensitivity	2
strong	5
Finally	1
AION	6
broader	1
applicable	1
Database	1
differential	1
age	7
respectively	1
regarding	1
Seroma	1
ultrasound	1
unenhanced	1
noncoding	1
towavelet	1
United	1
postmenopausal	1
0.70	1
co-encapsulation	1
neuroma	3
next	1
pathological	1
neural	1
such	9
formed	1
delay	1
intervention	1
missed	1
common	3
chemotherapy	3
suspicion	1
7/18	1
CONCLUSION	2
VEGFA	1
25	5
registries	1
Future	1
19450	1
required	1
substantially	1
paradigm	1
inconsistent	2
adjuvant	1
face-to-face	1
not	13
enable	2
conclusion	2
practice	1
provided	3
68Ga-Pentixafor	5
modalities	1
At	1
2016	1
generated	1
perceived	2
elderly	1
subgroup	1
AND	1
rights	1
tomosynthesis	1
usually	1
phase	2
exploit	1
PEGylated	1
increasing	2
mortality	1
tumor	10
malignancy	2
summarized	1
had	5
database	1
on	15
Management	1
before	6
Group	1
4.0%	1
random	1
175	1
and/or	2
factor	4
outpatient	1
overexpressed	2
deaths	2
similar	1
reviewed	1
cases	12
gadolinium-based	1
RESON	1
use	16
physical	1
onset	1
serve	3
pituitary	2
mode	4
Studies	1
compared	6
processing	1
triggered	1
50	1
tools	1
remained	1
500000	1
coronary	1
decades	2
lutein	1
ejection	2
GSK525762A	1
possibility	1
assessed	1
potentially	2
inhibitory	1
examined	2
seroma	7
53.7	1
crucial	1
TNBC	10
1444	1
These	4
optoacoustic	1
definitive	1
difficulty	1
PET	10
confirms	1
subcutaneous	1
selected	1
injury	2
immune	2
side	1
colon	2
also	3
wider	1
should	1
significant	4
Centre	1
prediction	2
latest	1
susceptibility	1
reported	8
up	1
evaluated	1
NST	1
Computer	2
limit	2
rates	1
dose-dependent	1
damage	4
BRCA1	5
shaped	1
cross-sectional	1
strategy	1
Early	1
by	17
Similar	1
membrane	4
52723	1
presenting	1
epigenetic	1
beam	1
14	1
growth	2
43.6	1
persistent	1
semi-quantitatively	1
expressed	2
external	1
chemokine	1
inhibitor/mimic-	1
dense	1
addressed	1
consistently	1
based	4
Many	1
course	1
refractory	1
highly	2
within	2
intensity	1
Hence	2
557	1
PARP	2
underlines	1
Multivariate	1
transforms	1
15.9	1
large	2
to	76
system-both	1
20%	1
normal	1
Raf	1
and	154
copyright	1
being	4
familial	1
additional	2
